Welcome to our dedicated page for Waystar Holding news (Ticker: WAY), a resource for investors and traders seeking the latest updates and insights on Waystar Holding stock.
Waystar Holding Corp (WAY) delivers cloud-based healthcare payment solutions that streamline billing processes through AI-driven automation. This page aggregates official announcements and market-moving developments for investors tracking this healthcare IT innovator.
Access real-time updates on earnings reports, strategic partnerships, and product enhancements directly from the source. Monitor operational milestones including platform expansions, regulatory compliance achievements, and technology integrations shaping modern healthcare administration.
Key coverage areas: quarterly financial results, client acquisition announcements, software feature updates, and leadership team changes. Our curated news feed provides essential context for understanding Waystar's role in transforming revenue cycle management through advanced automation tools.
Bookmark this page for efficient tracking of Waystar's progress in reducing administrative burdens for healthcare providers via its enterprise-grade payment platform. Stay informed about developments impacting the company's market position in healthcare financial technology.
Waystar (Nasdaq: WAY) unveiled significant AI-powered innovations at its Fall Innovation Showcase to address major healthcare payment challenges. The company's AltitudeAI platform targets three critical issues: $20 billion in denial recovery costs, $17 billion in uncompensated care, and $2.6 billion in manual payer reimbursement inefficiencies.
The platform demonstrates impressive results, including 90% time savings across key capabilities, 40% more denial overturns for early adopters, and an increase in pre-service patient payments from 17% to 40%. For mid-size health systems, the solution reduces denial appeal processing time from 38 hours to 2 hours and cuts denial prevention work from 133 hours to under 6 hours.
EQT has completed a significant public offering of Waystar Holding Corp. (NASDAQ: WAY) common stock. The offering involved approximately 18.0 million shares, generating total proceeds of $705.8 million for all selling stockholders. EQT sold about 7.8 million shares for proceeds of $304.5 million, retaining approximately 24.9 million shares after the transaction.
The offering, underwritten by J.P. Morgan Securities LLC, was completed on September 12, 2025. Notably, Waystar Holding Corp. did not sell any shares in this offering and received no proceeds from the transaction.
Waystar (NASDAQ: WAY), a healthcare payments software provider, has announced the pricing of a secondary offering where existing shareholders will sell 18 million shares at $39.40 per share. The selling stockholders include investment funds from EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board.
The offering is expected to close around September 12, 2025, with J.P. Morgan acting as the underwriter. Importantly, Waystar will not receive any proceeds from this secondary offering as the company is not selling any shares directly.
Waystar (NASDAQ: WAY), a healthcare payments software provider, has announced a secondary offering of 18 million shares of common stock. The offering is being conducted by existing shareholders including EQT AB, Bain Capital, and CPP Investments (the Selling Stockholders).
J.P. Morgan will serve as the underwriter for the offering, which will be made through a registration statement filed with the SEC. Importantly, Waystar will not receive any proceeds from this secondary offering as the company is not selling any shares directly.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has been named to Fast Company's 2025 Best Workplaces for Innovators in North America list. The company's cloud-based, AI-powered platform serves over 1 million providers and recently launched Waystar AltitudeAI™, focusing on claim denial prevention and recovery.
The recognition follows other notable accolades, including Forbes' Most Trusted Company in America, Fortune's Best Workplace in Health Care, and KLAS Research's Best in KLAS software platform awards. Waystar plans to showcase its latest innovations at its Fall Innovation Showcase during the annual Waystar True North™ client conference on September 16, 2025.
Waystar (Nasdaq: WAY) has announced its Fall Innovation Showcase, taking place at the sold-out Waystar True North client conference from September 15-17, 2025 in Nashville. The event's centerpiece will be the Innovation Showcase on September 16 at 11:30 a.m. ET, where the company will unveil new AI capabilities designed to enhance healthcare payment processes.
The conference will feature keynote speakers, expert-led sessions offering Continuing Education Credits, and demonstrations of Waystar's technology impact. The event will bring together healthcare leaders and the Waystar Advisory Board to address industry challenges and showcase solutions focused on revenue optimization and patient financial experience improvement.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has announced that CEO Matt Hawkins will present at the upcoming Goldman Sachs Communacopia + Technology Conference. The presentation is scheduled for September 10, 2025, at 3:05 p.m. PT.
Investors can access a live webcast of the presentation through Waystar's Investor Relations website. A recording of the presentation will be made available on the same platform following the event.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has secured multiple Gold Stevie® Awards in 2025, including Healthcare Company of the Year and Top-Ranked AI Software Platform for Waystar AltitudeAI™. The company's Auth Accelerate solution achieved industry-leading auto-approval rates exceeding 90% for prior authorizations.
Waystar AltitudeAI™, launched in 2025, has demonstrated significant impact with a 70% increase in appeal productivity and efficiency gains equivalent to 10 full-time employees for mid-size health systems. The company also announced plans to acquire Iodine Software to enhance its AI capabilities in clinical intelligence.
Waystar (Nasdaq: WAY), a healthcare payment software provider, has successfully repriced its first lien term loan due October 2029. The company secured a 25-basis-point reduction in interest rate to adjusted SOFR +2.00%. Additionally, Waystar will add $250 million of incremental term loans under the same terms to help fund the pending Iodine Software acquisition.
This marks Waystar's third successful repricing since its June 2024 IPO, resulting in a total reduction of 211 basis points in borrowing costs. The company's debt rating and stable outlook have been reaffirmed by major rating agencies S&P, Moody's, and Fitch.
Waystar (NASDAQ:WAY), a healthcare payment software provider, reported strong Q2 2025 financial results with revenue reaching $270.7 million, up 15% year-over-year. The company achieved a net income of $32.2 million with a 12% margin and an adjusted EBITDA of $112.6 million with a 42% margin.
Key performance metrics include 1,268 clients contributing over $100,000 in LTM revenue (up 14% YoY) and a net revenue retention rate of 115%. The company raised its full-year 2025 guidance, projecting revenue between $1.030-1.042 billion and adjusted EBITDA between $418-426 million.
Waystar also announced an agreement to acquire Iodine Software, an AI-powered clinical intelligence company, expected to expand their market reach and be accretive to their financial profile.
FAQ
What is the current stock price of Waystar Holding (WAY)?
What is the market cap of Waystar Holding (WAY)?
